Alterations in the expression of Per1 and Per2 induced by Aβ31-35 in the suprachiasmatic nucleus, hippocampus, and heart of C57BL/6 mouse

Brain Research

Volumn 1642, Issue , 2016, Pages 51-58

  Wang, Xiaohui ^a   Wang, Li ^a   Yu, Qianqian ^a   Xu, Yunyun ^a   Zhang, Lei ^b   Zhao, Xueling ^a   Cao, Xiuli ^a   Li, Yang ^a   Li, Lingmin ^a  

^a SHANXI MEDICAL UNIVERSITY   (China)

^b Shanxi Dayi Hospital   (China)

Author keywords

A 31 35; Heart; Hippocampus; Per1; Per2; SCN

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[31-35]; PER1 PROTEIN; PER2 PROTEIN; UNCLASSIFIED DRUG; CIRCADIAN RHYTHM SIGNALING PROTEIN; PEPTIDE FRAGMENT; PER1 PROTEIN, MOUSE; PER2 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CIRCADIAN RHYTHM; CONTROLLED STUDY; HEART; HIPPOCAMPUS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RUNNING; SUPRACHIASMATIC NUCLEUS; WESTERN BLOTTING; ALZHEIMER DISEASE; ANIMAL; BIOLOGICAL RHYTHM; C57BL MOUSE; CARDIAC MUSCLE; METABOLISM; MOTOR ACTIVITY; PATHOPHYSIOLOGY;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; BIOLOGICAL CLOCKS; CIRCADIAN RHYTHM; HIPPOCAMPUS; MICE; MICE, INBRED C57BL; MOTOR ACTIVITY; MYOCARDIUM; PEPTIDE FRAGMENTS; PERIOD CIRCADIAN PROTEINS; SUPRACHIASMATIC NUCLEUS;

EID: 84961898735     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2016.03.026     Document Type: Article

References (41)

1. H. Abe, S. Honma, M. Namihira, S. Masubuchi, M. Ikeda, S. Ebihara, and K. Honma Clock gene expressions in the suprachiasmatic nucleus and other areas of the brain during rhythm splitting in CS mice Brain 87 2001 92 99
2. J.F. Araujo, and N. Marques Circadian and ultradian rhythms of drinking behavior of albino rats maintained in constant darkness Braz. J. Med. Biol. Res. 29 1996 1369 1372
3. C.S. Atwood, and R.L. Bowen A Unified Hypothesis of Early- A nd Late-Onset Alzheimer's Disease Pathogenesis J. Alzheimers Dis. 47 2015 33 47
4. K. Bae, X. Jin, E.S. Maywood, M.H. Hastings, S.M. Reppert, and D.R. Weaver Differential functions of mPer1, mPer2, and mPer3 in the SCN circadian clock Neuron 30 2001 525 536
5. B. Bano Otalora, N. Popovic, J. Gambini, M. Popovic, J. Vina, V. Bonet-Costa, R.J. Reiter, P.J. Camello, M.A. Rol, and J.A. Madrid Circadian system functionality, hippocampal oxidative stress, and spatial memory in the APPswe/PS1dE9 transgenic model of Alzheimer disease: Effects of melatonin or ramelteon Chronobiol. Int. 29 2012 822 834
6. S. Bonney, D. Kominsky, K. Brodsky, H. Eltzschig, L. Walker, and T. Eckle Cardiac Per2 functions as novel link between fatty acid metabolism and myocardial inflammation during ischemia and reperfusion injury of the heart PLoS One 8 2013 e71493
7. J.A. Claassen New cardiovascular targets to prevent late onset Alzheimer disease Eur. J. Pharmacol. 763 2015 131 134
8. V.J. De-Paula, M. Radanovic, B.S. Diniz, and O.V. Forlenza Alzheimer's disease Subcell Biochem. 65 2012 329 352
9. C. Dibner, U. Schibler, and U. Albrecht The mammalian circadian timing system: Organization and coordination of central and peripheral clocks Annu. Rev. Physiol. 72 2010 517 549
10. M.J. Duncan, J.T. Smith, K.M. Franklin, T.L. Beckett, M.P. Murphy, D.K. St Clair, K.D. Donohue, M. Striz, and B.F. O'Hara Effects of aging and genotype on circadian rhythms, sleep, and clock gene expression in APPxPS1 knock-in mice, a model for Alzheimer's disease Exp. Neurol. 236 2012 249 258
11. C. Duyckaerts, B. Delatour, and M.C. Potier Classification and basic pathology of Alzheimer disease Acta Neuropathol. 118 2009 5 36
12. H.S. Hong, I. Maezawa, J. Petrlova, X.Y. Zhao, J.C. Voss, and L.W. Jin Tomoregulin (TMEFF2) Binds Alzheimer's disease Amyloid-beta (Abeta) Oligomer and AbetaPP and protects neurons from abeta-induced toxicity J. Alzheimers Dis. 2015
13. N.J. Izzo, J. Xu, C. Zeng, M.J. Kirk, K. Mozzoni, C. Silky, C. Rehak, R. Yurko, G. Look, G. Rishton, H. Safferstein, C. Cruchaga, A. Goate, M.A. Cahill, O. Arancio, R.H. Mach, R. Craven, E. Head, H. LeVine 3rd, T.L. Spires-Jones, and S.M. Catalano Alzheimer's therapeutics targeting amyloid beta 1-42 oligomers II: Sigma-2/PGRMC1 receptors mediate Abeta 42 oligomer binding and synaptotoxicity PLoS One 9 2014 e111899
14. C. Jud, I. Schmutz, G. Hampp, H. Oster, and U. Albrecht A guideline for analyzing circadian wheel-running behavior in rodents under different lighting conditions Biol. Proced. Online 7 2005 101 116
15. X.Y. Liao, M. Yamakawa, K. Shigenobu, S. Suto, and K. Makimoto Difference in sundowning of wandering behavior in patients with Alzheimer disease and frontotemporal dementia Zhonghua Yi Xue Za Zhi 92 2012 160 164
16. S. Libert, M.S. Bonkowski, K. Pointer, S.D. Pletcher, and L. Guarente Deviation of innate circadian period from 24 h reduces longevity in mice Aging Cell 11 2012 794 800
17. R.W. Logan, W.D. McCulley 3rd, J.A. Seggio, and A.M. Rosenwasser Effects of withdrawal from chronic intermittent ethanol vapor on the level and circadian periodicity of running-wheel activity in C57BL/6J and C3H/HeJ mice Alcohol. Clin. Exp. Res. 36 2012 467 476
18. K. Maemura, N. Takeda, and R. Nagai Circadian rhythms in the CNS and peripheral clock disorders: Role of the biological clock in cardiovascular diseases J. Pharmacol. Sci. 103 2007 134 138
19. E.S. Musiek, D.D. Xiong, and D.M. Holtzman Sleep, circadian rhythms, and the pathogenesis of Alzheimer disease Exp. Mol. Med. 47 2015 e148
20. K. Oishi, S. Higo-Yamamoto, S. Yamamoto, and Y. Yasumoto Disrupted light-dark cycle abolishes circadian expression of peripheral clock genes without inducing behavioral arrhythmicity in mice Biochem. Biophys. Res. Commun. 458 2015 256 261
21. J.S. Qi, L. Ye, and J.T. Qiao Amyloid beta-protein fragment 31-35 suppresses delayed rectifying potassium channels in membrane patches excised from hippocampal neurons in rats Synapse 51 2004 165 172
22. J. Raskin, J. Cummings, J. Hardy, K. Schuh, and R.A. Dean Neurobiology of Alzheimer's Disease: Integrated molecular, physiological, anatomical, biomarker, and cognitive dimensions Curr. Alzheimer Res. 12 2015 712 722
23. M.F. Rath, K. Rohde, J. Fahrenkrug, and M. Moller Circadian clock components in the rat neocortex: Daily dynamics, localization and regulation Brain Struct. Funct. 218 2013 551 562
24. J. Richards, K.Y. Cheng, S. All, G. Skopis, L. Jeffers, I.J. Lynch, C.S. Wingo, and M.L. Gumz A role for the circadian clock protein Per1 in the regulation of aldosterone levels and renal Na+ retention Am. J. Physiol. Renal Physiol. 305 2013 F1697 F1704
25. S.M. Rothman, N. Herdener, K.A. Frankola, M.R. Mughal, and M.P. Mattson Chronic mild sleep restriction accentuates contextual memory impairments, and accumulations of cortical Abeta and pTau in a mouse model of Alzheimer's disease Brain Res. 1529 2013 200 208
26. H. Song, M. Moon, H.K. Choe, D.H. Han, C. Jang, A. Kim, S. Cho, K. Kim, and I. Mook-Jung Abeta-induced degradation of BMAL1 and CBP leads to circadian rhythm disruption in Alzheimer's disease Mol. Neurodegener. 10 2015 13
27. G. Sorrentino, and V. Bonavita Neurodegeneration and Alzheimer's disease: The lesson from tauopathies Neurol Sci. 28 2007 63 71
28. D.L. Sparks, T.A. Martin, D.R. Gross, and J.C. Hunsaker 3rd Link between heart disease, cholesterol, and Alzheimer's disease: A review Microsc. Res. Tech. 50 2000 287 290
29. R. Sterniczuk, R.H. Dyck, F.M. Laferla, and M.C. Antle Characterization of the 3xTg-AD mouse model of Alzheimer's disease: Part 1. Circadian changes Brain Res. 1348 2010 139 148
30. L.R. Stow, J. Richards, K.Y. Cheng, I.J. Lynch, L.A. Jeffers, M.M. Greenlee, B.D. Cain, C.S. Wingo, and M.L. Gumz The circadian protein period 1 contributes to blood pressure control and coordinately regulates renal sodium transport genes Hypertension 59 2012 1151 1156
31. M.H. Vitaterna, J.S. Takahashi, and F.W. Turek Overview of circadian rhythms Alcohol Res. Health. 25 2001 85 93
32. L. Volicer, D.G. Harper, and E.G. Stopa Severe impairment of circadian rhythm in Alzheimer's disease J. Nutr. Health Aging 16 2012 888 890
33. L.M. Wang, J.M. Dragich, T. Kudo, I.H. Odom, D.K. Welsh, T.J. O'Dell, and C.S. Colwell Expression of the circadian clock gene Period2 in the hippocampus: Possible implications for synaptic plasticity and learned behaviour ASN Neuro 1 2009
34. J.P. Wisor, D.M. Edgar, J. Yesavage, H.S. Ryan, C.M. McCormick, N. Lapustea, and G.M. Murphy Jr. Sleep and circadian abnormalities in a transgenic mouse model of Alzheimer's disease: A role for cholinergic transmission Neuroscience 131 2005 375 385
35. A.W. Xiao, J. He, Q. Wang, Y. Luo, Y. Sun, Y.P. Zhou, Y. Guan, P.J. Lucassen, and J.P. Dai The origin and development of plaques and phosphorylated tau are associated with axonopathy in Alzheimer's disease Neurosci Bull. 27 2011 287 299
36. S. Yamaguchi, S. Mitsui, L. Yan, K. Yagita, S. Miyake, and H. Okamura Role of DBP in the circadian oscillatory mechanism Mol. Cell. Biol. 20 2000 4773 4781
37. M.E. Young The circadian clock within the heart: Potential influence on myocardial gene expression, metabolism, and function Am. J. Physiol. Heart Circ. Physiol. 290 2006 H1 H16
38. M.W. Young The tick-tock of the biological clock Sci Am. 282 2000 64 71
39. L. Zhao, Z.M. Qian, C. Zhang, H.Y. Wing, F. Du, and K. Ya Amyloid beta-peptide 31-35-induced neuronal apoptosis is mediated by caspase-dependent pathways via cAMP-dependent protein kinase A activation Aging Cell 7 2008 47 57
40. B. Zheng, D.W. Larkin, U. Albrecht, Z.S. Sun, M. Sage, G. Eichele, C.C. Lee, and A. Bradley The mPer2 gene encodes a functional component of the mammalian circadian clock Nature 400 1999 169 173
41. B. Zheng, U. Albrecht, K. Kaasik, M. Sage, W. Lu, S. Vaishnav, Q. Li, Z.S. Sun, G. Eichele, A. Bradley, and C.C. Lee Nonredundant roles of the mPer1 and mPer2 genes in the mammalian circadian clock Cell 105 2001 683 694